window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-ZXTT8H6EZ1');

iThera Medical reports initiation of fifth clinical site in EUPHORIA study for the non-invasive assessment of IBD

By |2022-06-22T08:41:19+01:00June 22nd, 2022|

Medical device company iThera Medical, our coordinator, announces that the fifth site has been initiated for the ongoing clinical study in the EUPHORIA project that aims to further develop the company’s proprietary optoacoustic imaging technology and demonstrate its clinical value in the assessment of inflammatory bowel disease (IBD). The EUPHORIA (Enhancing Ultrasound and PHOtoacoustics for [...]

iThera produces EUPHORIA clinical study management video

By |2022-06-13T14:09:06+01:00June 13th, 2022|

EUPHORIA Coordinator iThera Medical have released a new video to showcase the processes behind managing a multi-centre international clinical study to measure inflammation using their  MSOT technologies. The video features Claudia Jendrewski who takes us through the planning stages of preparation for the EUPHORIA clinical study protocol and recruitment processes. Watch it here. https://vimeo.com/719784005   [...]

World IBD Day 2022- the EUPHORIA message

By |2022-05-19T07:00:13+01:00May 18th, 2022|

Our 2022 social media campaign on May 19th, #WorldIBDDay includes the messages above and below. Endoscopy is frequently used to monitor IBD, inflammatory bowel disease but can be uncomfortable and expensive. New research and technologies are needed to develop accurate, non-invasive alternatives. The EU-funded EUPHORIA study is doing just that. In EUPHORIA, hospitals in Germany [...]

The EUPHORIA study features on the DCCV website!

By |2021-12-22T12:00:32+00:00December 22nd, 2021|

Through the European Federation of Crohn's & Ulcerative Colitis Associations (EFCCA),  an umbrella organisation representing 41 national Crohn’s and Ulcerative Colitis (collectively Inflammatory Bowel Disease or IBD) patient associations, we identified the German Crohn's disease and Ulcerative Colitis Association (DCCV, https://www.dccv.de/die-dccv/), the advocacy organization for more than 400,000 people with chronic inflammatory bowel disease in [...]

Training on MSOT Acuity Echo is happening in Rome!

By |2021-11-04T16:55:40+00:00November 4th, 2021|

Dr Yi Qiu, Application Specialist at iThera Medical is at the Policlinico Tor Vergata hospital in Rome this week. She is training the EUPHORIA clinical study staff there to use the iThera Acuity Echo system on November 3-5th, 2021. This site, Study site 4 will be initiated soon thereafter and then recruit patients to the [...]

Welcome to the EUPHORIA team, Claudia!

By |2021-10-18T08:24:19+01:00October 14th, 2021|

Claudia Jendrewski One hallmark of success is to see the size of the workforce at iThera Medical growing. One such recent addition has joined the team of researchers on the EUPHORIA project. We welcome Claudia Jendrewski, who joined ITM in October 2021 as a Clinical Trial Manager. Claudia is leading iThera-sponsored clinical investigations. [...]

PRESS RELEASE: iThera Medical reports initiation of second site in ongoing clinical study for the non-invasive assessment of inflammatory bowel disease

By |2021-09-23T14:52:54+01:00September 23rd, 2021|

Medical device company iThera Medical announces that the second site in Germany has been initiated for the ongoing clinical study in the EU-funded Horizon 2020 project EUPHORIA. The project aims to further develop the company’s proprietary optoacoustic imaging technology and demonstrate its clinical value in the assessment of inflammatory bowel disease (IBD). The €2.3 million [...]

Second German hospital registers participants in EUPHORIA IBD Study

By |2021-09-17T15:29:03+01:00September 17th, 2021|

The EUPHORIA study The EUPHORIA study is now open at the Universitätsklinikum Jena, Klinik für Innere Medizin IV in Jena, Germany. This is the second clinical study site running the EUPHORIA study in Germany and they are currently recruiting patients to take part. Two patients are already registered and scanned with the MSOT [...]

Partners Pintail Limited feature EUPHORIA on World IBD Day

By |2021-06-06T06:05:58+01:00May 30th, 2021|

"A new dawn of inflammatory bowel imaging technologies is on the horizon!"  is how our partners at Pintail Limited have described EUPHORIA in a May 19th, 2021, story on their website. To acknowledge World IBD Day, they shared the good news that "new non-invasive inflammatory bowel imaging technologies are trialling through the Horizon 2020-funded ‘EUPHORIA’ [...]

EUPHORIA clinical study receives Regulatory Approval in Italy

By |2021-06-02T08:14:42+01:00May 10th, 2021|

The EUPHORIA team at iThera Medical, sponsors of the EUPHORIA clinical study are pleased to announce that they have obtained full regulatory approval for the study in Italy. Currently, they are preparing the initiation of the Italian sites, and expect to open both Milan and Rome in June 2021. In Italy, who can you contact [...]

Go to Top